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Abstract
Radiotherapy of head and neck cancers often results in collateral damage to adjacent salivary glands associated with
clinically significant hyposalivation and xerostomia. Due to the reduced capacity of salivary glands to regenerate,
hyposalivation is treated by substitution with artificial saliva, rather than through functional restoration of the glands.
During embryogenesis, the ectodysplasin/ectodysplasin receptor (EDA/EDAR) signaling pathway is a critical element in the
development and growth of salivary glands. We have assessed the effects of pharmacological activation of this pathway in a
mouse model of radiation-induced salivary gland dysfunction. We report that post-irradiation administration of an EDAR-
agonist monoclonal antibody (mAbEDAR1) normalizes function of radiation damaged adult salivary glands as determined
by stimulated salivary flow rates. In addition, salivary gland structure and homeostasis is restored to pre-irradiation levels.
These results suggest that transient activation of pathways involved in salivary gland development could facilitate
regeneration and restoration of function following damage.
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Introduction
Approximately 40,000 new cases of head and neck cancer are
diagnosed each year in the United States with five year survival
rates around 64% [1]. Treatment for head and neck cancer
typically involves surgical resection with subsequent radiation or
chemoradiation therapy [2]. These necessary but tissue-nonspe-
cific treatment modalities are associated with inadvertent and
often clinically significant damage to surrounding normal tissues.
Side effects include mucositis, xerostomia, dysphagia and malnu-
trition. Loss of saliva production in these patients predisposes them
to periodontal disease, rampant caries, increased susceptibility to
oropharyngeal candidiasis, changes in taste, and significant
reductions in quality of life [3–5].
At a tissue level, salivary glands in close proximity to the tumor
exhibit both acute and chronic responses to radiation damage.
Depending upon the level of radiation exposure, chronic responses
may last months, years and even become permanent after
completion of radiation therapy [3–5]. A number of tissue
pathologies have been reported in irradiated salivary glands
including loss of acinar cells, focal inflammation, atrophy,
vacuolization, and fibrosis [4]. As a result there are a significant
number of patients who have completed their treatment regimen
that continue to suffer from these side effects [6]. The currently
available xerostomia treatment options are palliative at best and
are not considered a long-term solution [3].
It has been postulated that tissue regeneration following injury
may recapitulate normal development and utilize molecular
signaling pathways active in organ morphogenesis [7]. The
murine Tabby mutant is deficient in the key ectodermal signaling
molecule ectodysplasin-A1 (EDA), which is required during
prenatal development to trigger signal transduction from its
receptor EDAR, thereby initiating development and morphogen-
esis of a range of structures, including hair follicles, teeth, and a
number of glands, including salivary glands [8]. Absence of this
signal results in generalized secretory gland hypoplasia including
reduced salivary gland branching, weight, and secretory output
[9]. This phenotype can be reversed in organ culture of embryonic
Tabby salivary glands by administering exogenous EDA-A1
protein [10,11]. Tabby is an animal model for the human
ectodermal disorder XLHED (X-linked hypohidrotic ectodermal
dysplasia), which is also caused by mutation of the EDA gene, and
patients affected by XLHED have been demonstrated to have
reduced salivary output.
A majority of salivary gland regeneration studies have focused
on the ductal ligation protocol which involves surgical placement
of a metal clip over the main excretory ducts of the submandibular
salivary glands for 1–2 weeks followed by removal of the clip.
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Within 3–8 weeks of deligation, submandibular glands restore
excretory function and glandular structure [12]. Embryonic-like
branched structures can be detected during early time points
following deligation (3–7 days) and these structures have been
hypothesized to play a critical role in regeneration of acinar cells
that were lost during the ligation phase [13,14]. EDA/EDAR
mediated signaling has been shown to promote branching
morphogenesis during salivary and mammary gland development
[9,15]; however its role in regeneration is currently unknown.
Modulation of the EDAR pathway activity in adults has become
possible with the development of pharmacological agents to
stimulate signaling (recombinant EDA or monoclonal antibodies
against EDAR) or to block endogenous EDA-A1 from binding to
its receptor (monoclonal antibodies against EDA) [8]. mAbE-
DAR1 is an agonist monoclonal antibody that binds specifically to
the extracellular domain of EDAR and activates the downstream
EDA/EDAR signaling pathway [16]. In both mouse and dog
models of XLHED, a single administration of mAbEDAR1
corrected the EDA-deficient hair and sweat gland phenotype
demonstrating the functional equivalence of mAbEDAR1 and
EDA ligand [16]. Based on the key role of EDA/EDAR signaling
in embryonic salivary gland development, we hypothesized that
mAbEDAR1 activation of this signaling pathway following head
and neck irradiation could enhance salivary gland regeneration
and reduce the clinically significant complications associated with
xerostomia. We have used a mouse model to test this hypothesis,
incorporating a 5 Gy single dose irradiation to the head and neck
area, which includes major and minor salivary glands. We assessed
the role of exogenously driven EDAR pathway activation in
stimulating salivary gland regeneration and functional recovery
from 3 days post-irradiation through day 90, similar to previous
restoration models [17]. In this system we report that post-
irradiation mAbEDAR1 therapy induces structural and functional
restoration of salivary glands.
Materials and Methods
Mice Treatment
Experiments were conducted on 5 week old female FVB mice
(Taconic Farms, Oxnard, CA). Mice were housed and treated in
accordance with protocols approved by the University of Arizona
Institutional Animal Care and Use committee (IACUC). On day
zero, mice were anesthetized with an intramuscular injection of
Ketamine/Xylazine (50 mg/kg/10 mg/kg respectively; Western
Medical Supply, Arcadia, CA). Mice were then placed in a holding
device, with the head and neck region exposed, while the
remainder of the body was shielded with .0.6 mm of lead. Mice
were irradiated with a single 5 Gy dose of radiation (day 0 of time
course). On day four, a sub-group of untreated and irradiated mice
received a single tail vein injection of mAbEDAR1 (5 mg/kg in
PBS, Edimer Pharmaceuticals, Cambridge, MA) similar to a
previous study using this compound [16]. The rationale for
systemic (iv) administration of mAbEDAR included previous work
on the functionality and half-life of mAbEDAR by this route, the
feasibility of one injection reaching all major and minor salivary
glands, and the greatest translatability to the clinical setting. The
remaining untreated and irradiated mice received a vehicle (PBS)
injection. All experiments were approved by IACUC.
RNA isolation and RT/PCR Analysis
Total RNA was isolated from the parotid glands using the
RNeasy isolation kit (Qiagen, Germantown, MD, USA) with
DNase treatment and diluted to 200 ng/mL [18]. 5 mL of diluted
RNA was added to 1 mL of Oligo(dT)20, 1 mL H2O and 1 mL of
Annealing Buffer. This was heated to 65uC for 5 minutes, and
cooled on ice for 1 minute. 10 ml of 2X First-Strand Reaction Mix
and 2 ml of SuperScript III/RNAseOUT Enzyme Mix (Invitro-
gen, Carlsbad, CA, USA) were added and the reaction was
incubated for 50 minutes at 50uC and 5 minutes at 85uC. cDNA
was diluted with 80 mL of H2O for real-time PCR reaction. Each
real-time PCR reaction contained 5 ml of diluted cDNA, 1 ml of
each primer at 10 mM each, 12.5 ml SYBR Green (Qiagen), and
nuclease-free water for a final volume of 25 ml. Forward and
reverse primer (IDT, San Diego, CA) sequences are as follows:
EDAR forward, TGTCCTCCATGCAGACCAG; EDAR re-
verse, GCATATCTGATAACCTCCTTTGG; S15 forward, AT-
CATTCTGCCCGAGATGGTG; S15 reverse, TGCTTTACG-
GGCTTGTAGGTG. Reactions were conducted in triplicate for
each sample using the iQ5 Real-Time PCR Detection System
(Bio-Rad, Hercules, CA). PCR conditions were, 95uC for 15
seconds, 54uC for 30 seconds, 72uC for 30 seconds for 40 cycles.
Detection occurred during the 72uC step during each cycle. The
data were analyzed using a 2DDCt method [19]. Thresholds cycle
values were normalized to S15. Normalized values from 4 mice/
group are represented as relative fold over untreated.
Saliva Collections
Stimulated saliva collections were performed according to
previously published reports [17,20–25]. Mice received an
intraperitoneal injection of carbachol 0.25 mg/kg (Sigma-Aldrich,
St. Louis, MO) to stimulate salivary flow. Mice were then placed
into a restraining device and saliva was collected for 5 minutes into
weighed tubes on ice. Five minute collections on unanaesthetized
mice were conducted according to a previously published study
[26] and chosen to minimize the stress to the animals. Once
completed, samples were then frozen on dry ice. Salivary flow
rates (mg/min) were determined by calculating the change in
collection tube weight (post-pre) divided by the collection time
(5 min). The average mg/min value for the untreated animals was
set to 100% (normalized value of 1) for each collection day. Each
mg/min value for the experimental animals was divided by the
average untreated mg/min value for each collection day to
determine the percent change. Similar to our previous studies,
no significant differences in body weight between the treatment
groups were detected; therefore body weight is not used in the
salivary flow rate calculation. Collections were performed on days
3, 14, 30, 60 and 90 post-irradiation with.16 mice per treatment.
Tissue collection
Following anesthesia, salivary glands were removed, immedi-
ately fixed for 24 hours with 10% formalin (Fisher Diagnostics,
Kalamazoo, MI) and then transferred to 70% ethanol. Tissue was
embedded into paraffin, cut to 4 mm sections, and stained with
hemotoxylin and eosin by the Histology Service Laboratory in the
Department of Cellular and Molecular Medicine at the University
of Arizona.
Vacuole analysis
For each mouse, two images of hemotoxylin and eosin stained
submandibular gland sections were collected at non-overlapping
locations close to the center of the gland. Images were taken at
200X. Using ImagePro (Media Cybernetics, Silver Spring, MD)
software, a subregion within each image was defined to avoid
gland edges, large lumens, fissures, and large blood vessels. Within
this area of interest each vacuole, defined as an unstained, acellular
area greater than 7.35 mm in diameter, was outlined to determine
its area. Unstained areas were not included for measurement if
Activation of EDA/EDAR Pathway Restores Function following Damage
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they were epithelially bounded (i.e. the unstained region was a
lumen) or if they were long fissures related to the lobular structure
of the gland. Clusters of vacuoles separated only by a thin strand of
cytoplasm, and not separated by any cell nuclei, were measured as
a single vacuole. Area data for vacuoles from a given image were
summed using ImagePro software and used to determine the
proportion of total area of interest that was represented by
vacuoles. The values for the two images collected from each
animal were averaged to yield a vacuole percentage for each
animal and these results were then evaluated for each treatment
group (N=4/group). All vacuoles were in the acinar compartment
and no vacuoles were found within the ductal compartment.
Amylase staining
Serial sectioned unstained slides were incubated at 37uC for 30
minutes. Paraffin was removed though incubation in Histo-Clear
(National Diagnostics, Atlanta, GA) followed by rehydration
washes in 100%, 95%, 70%, 50% ethanol and deionized water.
Peroxidases were neutralized with 0.3% H2O2 (Fisher Scientific,
Fair Lawn, NJ). Slides in 10 mM citric acid (pH 6.0) were heated
in a microwave for two 5 minute intervals then cooled for 20
minutes at room temperature. Slides were washed with PBS,
blocked with 0.5% NEN (Boston, MA) at room temperature for
1 hour, and then incubated in anti-amylase primary antibody
(1:1000) overnight at 4uC (Sigma-Aldrich). Slides were washed and
incubated in secondary antibody Anti-Rabbit AlexaFluor594
(1:500) (Invitrogen) at room temperature for 1 hour, counter-
stained with DAPI, then mounted with 50% glycerol in 10 mM
Tris-HCl (pH 8.0). Images were obtained using a Leica DM5500
Microscope System and captured with a Spot Pursuit 4 Megapixel
CCD camera (Diagnostic Instruments, Inc., Sterling Heights, MI).
Analysis was performed with ImagePro 6.3 software. Amylase-
positive area was measured from twenty fields of view
(FOV=0.39 mm2) per mouse with 4 mice per treatment. Data
are shown as the percent of amylase positive area to the total area
of the parotid gland.
PCNA staining
Serial sectioned unstained slides were incubated at 37uC for 30
minutes. Paraffin removal, rehydration, peroxidase neutralization
and antigen retrieval were performed as described above for
amylase staining. Slides were washed with PBS, blocked with goat
serum from the ABC Rabbit Kit (Vector Laboratories, Burlin-
game, CA) and then incubated with anti-PCNA antibody (Santa
Cruz Biotechnology) overnight at 4uC. Slides were washed and
incubated in secondary antibody from the ABC Rabbit Kit. Color
detection utilized DAB (Biogenex Laboratories, Fremont, CA) for
6 min per slide. Slides were counterstained using Harris hema-
toxylin (Sigma-Aldrich, St. Louis, MO), dehydrated, and mounted
using Protocol Securemount (Fisher Scientific). Images were
obtained using a Leica DM5500 and 4 megapixel Pursuit camera.
PCNA-positive and total acinar cells in the parotid gland were
counted manually from at least 3 fields per slide at 200X. Data are
graphed as a percentage of PCNA positive acinar cells to total
acinar cells from 4 mice per treatment.
Statistical analysis
Salivary flow rates were normalized by collection day to
corresponding untreated group for each time point and analyzed
by ANOVA with a Student-Newman-Keuls post-hoc test. For
Figure 1C only, salivary flow rate comparison between unirradi-
ated (UT) and irradiated (5Gy) was determined by t-test using
Microsoft Excel. Real-time RT/PCR, vacuole area, amylase area
and PCNA indices were analyzed by ANOVA with a Bonferroni
post-hoc test. Statistical analysis of data and graph generation was
completed using Graph-Pad software. All error bars represent
standard error of the mean (SEM). Multiple comparison statistical
differences are represented by lower case letters within individual
graphs. Treatment groups with the same letters are not
significantly different from each other. Therefore if a group is
designated as ‘‘a’’ then it is statistically different from a group
designated as ‘‘b’’ or ‘‘c’’. If a group is designated as ‘‘ab’’ then it is
not statistically different from a group designated as ‘‘a’’ or ‘‘b’’.
Results
EDA receptor levels are maintained at day 4 and
progressively decline at days 5–10 following radiation
Activation of the EDA/EDAR signaling pathway by mAbE-
DAR1 relies on endogenous expression of the EDA-A1 receptor
(EDAR). We sought to determine the effect of radiation on Edar
expression levels over a time period similar to previously published
salivary restoration studies (days 4–10; Figure 1A). Multiple
comparison statistics were completed to compare each time point
and treatment groups with the same letters are not significantly
different from each other. Four days after radiation treatment,
Edar levels were not statistically different (both within statistical
group ‘‘a’’) from unirradiated controls (UT). At day 5, Edar levels
began to decline (not statistically different from unirradiated
controls or radiation day 4) and by radiation days 6–10 were
significantly reduced at when compared to unirradiated controls.
Therefore the experimental design (Figure 1B) utilized an injection
of mAbEDAR1 on day 4, which is after the significant reductions
in salivary flow rates (day 3, Figure 1C) but prior to reductions in
Edar expression (Figure 1A).
mAbEDAR1 administration following radiation restores
stimulated salivary flow rates to pretreatment levels
Once significant reductions in salivary flow rates were
confirmed in irradiated animals (Figure 1C), mice were random-
ized into mAbEDAR1 or vehicle control treatment groups and
respective injections were administered on day 4. Stimulated
salivary flow rates were again determined at days 14, 30, 60 and
90 following radiation treatment (Figure 2) with multiple compar-
ison statistics completed by time point (treatment groups with the
same letters are not significantly different from each other). On
average, untreated flow rates were ,27 mg/min across all time
points. At day 14, irradiated animals had significant reductions in
stimulated salivary flow rates (statistical group ‘‘c’’) when
compared to unirradiated controls (CTRL, statistical group ‘‘a’’).
In contrast, animals receiving post-therapy mAbEDAR1 have
improved stimulated salivary flow rates (statistical group ‘‘b’’) that
are significantly higher than irradiated animals, albeit the levels
have not reached unirradiated controls. Following these animals
from days 30–90 revealed that post-therapy mAbEDAR1 was able
to restore stimulated salivary flow rates to untreated levels (both
statistical group ‘‘a’’) while irradiated animals continued to display
reduced function. Treatment with mAbEDAR1 alone did not alter
stimulated salivary flow rates at days 30 and 90; however salivary
secretion was significantly higher in these animals at day 60. It is
unclear why treatment with mAbEDAR alone resulted in elevated
secretion at one intermediate time point (day 60), while it was
similar to untreated controls at days 14, 30 and 90. Overall, these
results suggest that post-therapy mAbEDAR1 is able to restore
secretion in salivary glands that have been damaged by radiation.
Activation of EDA/EDAR Pathway Restores Function following Damage
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Increased vacuolization in irradiated salivary glands is
reversed with post-therapy mAbEDAR1
Previously described histological changes in salivary glands
following radiation consist of focal inflammation, atrophy and
fibrosis [4]. Analysis of H&E sections from the current study
revealed similar histological alterations as previous reports
(pathologic features noted with arrowheads and asterisks in
Figure 3 and data not shown) as well as the presence of cellular
vacuoles in irradiated sections of the submandibular salivary
gland. Vacuoles were defined as an unstained, acellular area
greater than 7.35 mm in diameter that did not denote a lumen and
were outlined to determine their aggregate area (representative
annotated image in Figure 4A). The most prominent differences
were detected at day 60 post-irradiation; therefore this time point
was selected for further analysis. The percent area occupied by
vacuoles (combined annotated area/total area) was significantly
higher in irradiated submandibular glands when compared to
unirradiated controls (Figure 4B). Importantly, the percent area
with vacuoles in animals receiving mAbEDAR1 following
radiation was not different from untreated controls. These data
suggest that radiation induces persistent histological changes in
salivary gland structure that is repaired in animals treated with
post-irradiation mAbEDAR1.
Restoration of amylase positive area in parotid glands of
mice treated with post-therapy mAbEDAR1
Saliva production requires the movement of water as well as the
production of numerous salivary proteins [27]. Amylase is a
salivary protein made by parotid salivary glands that is frequently
reduced following radiation treatment [17,25,28]. Therefore we
determined the area of the parotid gland that had restored amylase
Figure 1. Analysis of Edar expression following radiation and
experimental design of study. (A) On day 0 the head and neck
region of mice was exposed to a single dose of 5 Gy radiation. Edar
expression (mRNA) in parotid salivary glands was determined on days
4–10 post-radiation as described in the materials and methods and
graphed as fold over unirradiated (UT). Significant differences (p,0.05)
were determined using an ANOVA followed by a Bonferroni post-hoc
test. Treatment groups with the same lower case letters are not
significantly different from each other. N = 4 mice per group. (B)
Experimental design timeline. (C) Three days post-radiation stimulated
salivary flow rates were determined as described in the materials and
methods. Irradiated flow rates were normalized to corresponding
unirradiated (UT) controls. There were 60 animals in the control (UT)
and 62 animals in the irradiated group (5Gy). Significant difference (p,
0.05) was determined by t-test and designated by an asterisk (*). All
error bars represent standard error of the mean (SEM).
doi:10.1371/journal.pone.0112840.g001
Figure 2. mAbEDAR1 administration following radiation re-
stores stimulated salivary flow rates to pretreatment levels. On
day 0, the head and neck region of mice was exposed to a single dose
of 5 Gy radiation. On day 4, mice received a single dose injection of
mAbEDAR or vehicle control. Stimulated salivary flow rates were
determined on days 14, 30, 60, 90 post-irradiation. Flow rates (mean+/2
SEM) were calculated by determining the average mg/min value for the
unirradiated controls (CTRL) for each collection day followed by the
percent change in individual experimental animals. Unirradiated
controls averaged ,27 mg/min across all time points and were set to
100% (normalized value of 1) for each time point. Significant differences
(p,0.05) were determined using an ANOVA followed by a Student-
Newman-Keuls post-hoc test. Treatment groups with the same lower
case letters are not significantly different from each other. All error bars
represent standard error of the mean (SEM). N.16 mice per group.
doi:10.1371/journal.pone.0112840.g002
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Figure 3. Histological analysis of salivary glands. Mice were treated as described in Figure 2 and submandibular salivary glands were collected
at day 60 for histological analysis. Representative H&E images from unirradiated control (A), mAbEDAR1 alone (B), irradiated with 5Gy (C) and 5Gy+
mAbEDAR are shown (D). Areas of focal inflammation denoted with asterisks and vacuoles are delineated by an arrowhead.
doi:10.1371/journal.pone.0112840.g003
Figure 4. Increased vacuolization in irradiated salivary glands is reversed with post-therapy mAbEDAR1. H&E images from
submandibular salivary glands were analyzed for cellular vacuoles as described in the materials and methods. Vacuoles were defined as an unstained,
acellular area greater than 7.35 mm in diameter. (A) Representative annotated image of vacuole measurement compared to the unmarked image is
shown. ImagePro software was utilized to calculate the area annotated as a vacuole compared to the total area in the image. (B) Quantification of the
percent area occupied by cellular vacuoles (mean+/2SEM) is graphed. Significant differences (p,0.05) were determined using an ANOVA followed by
a Bonferroni post-hoc test. Treatment groups with the same lower case letters are not significantly different from each other. All error bars represent
standard error of the mean (SEM). N = 4 mice per group.
doi:10.1371/journal.pone.0112840.g004
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protein production through morphometric analysis at days 30, 60
and 90 (Figure 5). Irradiated parotid glands had significant
reductions in the area expressing amylase when compared to
untreated controls at each time point evaluated. In contrast,
animals receiving mAbEDAR1 following radiation had restored
amylase expression in the parotid gland and there was no statistical
difference from untreated controls at each time point evaluated.
Similarly, animals treated with mAbEDAR1 alone did not display
significant changes in amylase area in the parotid gland at each
time point evaluated. These data suggest that post-therapy
mAbEDAR1 restores amylase protein production in parotid
glands damaged by radiation.
Reduced compensatory proliferation in mice treated with
post-therapy mAbEDAR1
Glandular homeostasis requires a balance between proliferation
and differentiation. Radiation damage causes apoptosis of salivary
acinar cells [20,29] and loss of these cells induces a proliferation
response in the surrounding cells [17]. This compensatory
proliferation response is intended to replace the cells lost to
apoptosis [30]; however prolonged increases in proliferation are
correlated with reductions in salivary flow rates [17]. Therefore we
determined the level of proliferation through PCNA staining and
quantification of the number of positive cells in the acinar
compartment at days 30, 60 and 90 (Figure 6). At each time point
evaluated, irradiated animals have significant increases in the
number of PCNA positive cells when compared to untreated
controls. In contrast, animals receiving mAbEDAR1 following
radiation have reduced numbers of PCNA positive cells which
does not differ from untreated controls each time point evaluated.
Animals treated with mAbEDAR1 alone exhibited more variation
in proliferation levels; however this group was not statistically
different from untreated controls at each time point evaluated
(mAbEDAR statistical group ‘‘ab’’ is not different from statistical
group ‘‘a’’). These results suggest that salivary gland homeostasis,
as well as histological structure and glandular function, are
restored in animals treated post-therapy with mAbEDAR1.
Discussion
Due to the chronic effects of radiation on salivary gland
function, there are numerous patients who have completed their
anti-cancer therapy yet still suffer the side effects of that therapy.
Currently there are few approved therapies that can substantially
improve the quality of life for these individuals [3]. In this
preclinical study we have investigated a new therapeutic for its
potential use in restoring salivary gland function following
radiotherapy. Utilization of mAbEDAR1 in animals with radia-
tion-induced loss of function led to an improvement in physiolog-
ical function of the salivary glands at day 14 and a complete
restoration of function by day 30 (Figure 2). This improvement in
function was maintained to 90 days post radiation. Restoration of
salivary gland function has been previously described utilizing
gene therapy with Adenoviral vectors or growth factors (IGF1 or
KGF) [6,17,31,32]. Adenoviral restoration of salivary gland
Figure 5. Restoration of amylase positive area in parotid glands of mice treated with post-therapy mAbEDAR1. Mice were treated as
described in Figure 2 and parotid salivary glands were collected at days 30, 60, and 90 for analysis of amylase area. (A) Representative images from
each treatment group are shown. Quantification of the mean area of parotid tissue staining positive for amylase was performed as described in the
materials and methods at days 30 (B), 60 (C) and 90 (D). Significant differences (p,0.05) were determined using an ANOVA followed by a Bonferroni
post-hoc test. Treatment groups with the same lower case letters are not significantly different from each other. All error bars represent standard
error of the mean (SEM). N= 4 mice per group.
doi:10.1371/journal.pone.0112840.g005
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function has primarily focused on increasing expression of a water
channel (aquaporin 1) via local injection into salivary glands [32].
This results in improved salivary output within three days and
subsequent studies have extended this effect in a phase I clinical
trial [6]. The results in the current study are similar to a previous
study with post-radiation injections of Insulin-like Growth Factor 1
(IGF1). Post therapy injections of IGF1 resulted in improved
salivary output at day 30 and complete restoration by day 60 [17].
Post therapy injection of mAbEDAR resulted in an expedited
response with improved salivary output at day 14 and complete
restoration by day 30 (Figure 2). In contrast, post-radiation
injections of Keratinocyte Growth Factor (KGF) did not show
improvement in salivary output at day 30 [31]. Importantly,
mAbEDAR1 was administered through a single systemic injection
while IGF1 was given over multiple injections. The effectiveness of
a single administration of mAbEDAR1 may be due to the long
half-life of this antibody, estimated at approximately 11 days in
vivo [16]. Thus it is likely that sustained stimulation of the EDAR
pathway was achieved in these experiments and the beneficial
effect of treatment on salivary function persists beyond the time of
plasma antibody clearance, as indicated by the sustained
restoration measured at 90 days post-irradiation. While the
objective measurement of salivary output does not always correlate
with the subjective symptom of xerostomia [3], a recent clinical
trial examining the re-expression of aquaporin channels following
radiation suggests that increasing fluid movement has a positive
effect on xerostomia [6].
The presence of cytoplasmic vacuoles has been previously
reported in both parotid and submandibular salivary glands [33–
36]. Early ultrastructural analysis using electron microscopy of
irradiated parotid glands detected small vacuoles four days after
treatment [33]. Most studies have reported the histological
presence of vacuoles at acute time points (up to 10 days); however
a few studies looked at more chronic time points (60–90 days) [34–
36]. We have extended this analysis by quantifying the percentage
of salivary gland area occupied by vacuoles following radiation
(Figure 4). Importantly, injection of mAbEDAR1 post-radiation
was able to reduce the aggregate area with vacuoles in the
submandibular glands and restore the overall histological structure
to that of an unirradiated state (Figure 4). The presence of
vacuoles has also been reported upon acute starvation of rats with
small vacuoles appearing in salivary glands at 24 hours that
increase in size at 72 hours [37]. However in the current study,
irradiated animals continue to eat and do not lose more than 10%
body weight so reductions in food intake do not appear to explain
the chronic presence of these vacuoles.
Saliva is a complex fluid and requires the movement of water
through aquaporin channels and the production of saliva proteins
by the acinar cells [27]. Therefore, alterations to the differentiation
state of the gland can adversely affect these crucial functions.
Clinically, radiation exposure to salivary glands leads to a loss of
Figure 6. Reduced compensatory proliferation in mice treated with post-therapy mAbEDAR1. Mice were treated as described in Figure 2
and parotid salivary glands were collected at days 30, 60, and 90 for analysis of PCNA levels. (A) Representative images from each treatment group are
shown. The total number of PCNA positive cells in the acinar compartment was graphed as a percentage of total number of cells in the acinar
compartment at days 30 (B), 60 (C) and 90 (D). Significant differences (p,0.05) were determined using an ANOVA followed by a Bonferroni post-hoc
test. Treatment groups with the same lower case letters are not significantly different from each other. All error bars represent standard error of the
mean (SEM). N = 4 mice per group.
doi:10.1371/journal.pone.0112840.g006
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amylase production and secretion, which has been recapitulated in
animal models [17,25,28]. In addition, the loss of salivary acinar
cells following radiation treatment induces a compensatory
proliferation response to replace these cells [38–40]. However if
proliferation remains elevated, it correlates with chronic loss of
salivary gland function [17]. Since mAbEDAR1 was able to
restore salivary secretion, it was important to validate that
glandular homeostasis was also restored through amylase area
analysis and proliferation indices. Similar to previously published
models, radiation treatment led to reductions in amylase area
(Figure 5) and increases in proliferation indices (Figure 6), which
are indicative of an overall decrease in differentiation. In contrast,
treatment with mAbEDAR1 following radiation led to improved
amylase area and decreased compensatory proliferation which is
indicative of restored homeostasis. Relatively few studies have
confirmed improvements in secretion with salivary protein
production. The effects of mAbEDAR1 on glandular homeostasis
are similar to the model of IGF1 restoration [17]. This suggests
that therapies which target improving the balance between
differentiation and proliferation could restore function in this
population.
Mouse models with defects in EDA or EDAR have both acinar
and ductal phenotypes suggesting this pathway is important to a
majority of salivary cells. In situ hybridization or immunohisto-
chemistry detection of EDA/EDAR has been conducted on
developmental time points in the submandibular gland and have
shown the presence of EDA/EDAR in ducts and terminal end
buds [9,10]. In addition, it has been previously demonstrated that
EDA is required for epithelial differentiation of the salivary gland
[9]. Since acinar cells undergo apoptosis at acute time points (,
48 hr) following radiation, it is possible that the EDA pathway
facilitates the differentiation step of new acinar cells during
regeneration.
This is the first study to our knowledge that utilizes pharma-
cological activation of a developmentally relevant pathway in
reversing radiation damage to salivary glands. EDAR signaling has
been shown to promote epithelial expansion and branching in
cultured embryonic salivary glands [9,10], and, in vivo, high level
EDAR function in transgenic mice results in more highly
branched adult salivary glands [41]. Embryonic-like branched
structures also appear to be important in regeneration of adult
mouse salivary glands following ductal ligation/deligation [13,14]
and these structures could be responsive to EDAR stimulation.
However, significant reductions in Edar expression several days
after irradiation (Figure 1A) could confound the ability of salivary
glands to regenerate by limiting the presence of these regenerative
branching structures. In addition to its effects on branching
morphology, loss of EDAR function also leads to impaired cellular
differentiation and duct formation [9]. Administration of mAbE-
DAR following radiation resulted in improved histological
structure and amylase area (differentiation marker) suggesting a
role in tissue pathology recovery and facilitation of differentiation
during regeneration. (Figures 3 and 5). It would be of interest to
determine whether there are commonalities in the cellular and
molecular mechanisms of action of EDAR stimulation in the
context of regenerating, as opposed to developing, salivary glands.
It has been previously shown that EDAR signaling is not necessary
for initiation of salivary glands which suggests this pathway may
not affect stem cells during development [9]; however future
studies could address the involvement of EDAR signaling in repair
and regeneration. While exploratory in nature, these results
highlight the potential for novel therapeutic paradigms to address
a significant unmet medical need in the field of head and neck
oncology.
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